To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Cardioembolic and Small V… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Cardioembolic and Small Vessel Disease Stroke Show Differences in Associations between Systemic C3 Levels and Outcome

Journal article
Authors Anna Stokowska
Sandra Olsson
Lukas Holmegaard
Katarina Jood
Christian Blomstrand
Christina Jern
Marcela Pekna
Published in Plos One
Volume 8
Issue 8
ISSN 1932-6203
Publication year 2013
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Language en
Links dx.doi.org/10.1371/journal.pone.007...
Keywords ACUTE ISCHEMIC-STROKE, COMPLEMENT COMPONENT C5A, CARDIOVASCULAR EVENTS, REACTIVE PROTEIN, BRAIN ISCHEMIA, ATHEROSCLEROSIS, ACTIVATION, MICE, INJURY, NEUROPROTECTION
Subject categories Neuroscience

Abstract

Background: Activation of the complement system has been proposed to play a role in the pathophysiology of stroke. As the specific involvement of the complement proteins may be influenced by stroke etiology, we compared plasma C3 and C3a levels in patients with cardioembolic (CE) and small vessel disease (SVD) subtypes of ischemic stroke and control subjects and evaluated their association to outcome at three months and two years. Methodology/Principal Findings: Plasma C3 and C3a levels in 79 CE and 79 SVD stroke patients, sampled within 10 days and at three months after stroke, and age- and sex-matched control subjects from The Sahlgrenska Academy Study on Ischemic Stroke were measured by ELISA. Functional outcome was assesed with modified Rankin Scale. In the CE group, plasma C3 levels were elevated only in the acute phase, whereas C3a was elevated at both time points. The follow-up phase plasma C3 levels in the upper third were associated with an increased risk of unfavorable outcome at three months (OR 7.12, CI 1.72-29.46, P = 0.007) as well as after two years (OR 8.25, CI 1.61-42.28, P = 0.011) after stroke. These associations withstand adjustment for age and sex. Conversely, three-month follow-up plasma C3a/C3 level ratios in the middle third were associated with favorable outcome after two years both in the univariate analysis (OR 0.19, CI 0.05-0.82, P = 0.026) and after adjustment for age and sex (OR 0.19, CI 0.04-0.88, P = 0.033). In the SVD group, plasma C3 and C3a levels were elevated at both time points but showed no significant associations with outcome. Conclusions: Plasma C3 and C3a levels are elevated after CE and SVD stroke but show associations with outcome only in CE stroke.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://gu.se/english/research/publication/?tipFriend=true&tipUrl=http%3A%2F%2Fgu.se%2Fenglish%2Fresearch%2Fpublication%2F%3FlanguageId%3D100001%26disableRedirect%3Dtrue%26returnUrl%3Dhttp%253A%252F%252Fgu.se%252Fforskning%252Fpublikation%252F%253FpublicationId%253D185485%26publicationId%3D185485&languageId=100001&disableRedirect=true&returnUrl=http%3A%2F%2Fgu.se%2Fforskning%2Fpublikation%2F%3FpublicationId%3D185485&publicationId=185485
Utskriftsdatum: 2020-04-07